(Q79660741)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253134%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

Continuous versus cyclic mesalazine therapy for patients affected by recurrent symptomatic uncomplicated diverticular disease of the colon (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253134%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Antonio Tursi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253134%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Giovanni Brandimarte

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253134%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Gian Marco Giorgetti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253134%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Walter Elisei

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253134%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253134%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253134%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253134%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253134%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

671-674

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17253134%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10620-006-9551-0

24 December 2019

exact match

0 references

cites work

Efficacy of mesalazine in the treatment of symptomatic diverticular disease

1 reference

12 December 2020

The pathology of diverticulosis coli

1 reference

12 December 2020

Acute diverticulitis of the colon--current medical therapeutic management

1 reference

12 December 2020

The natural history of diverticulitis: fact and theory

1 reference

12 December 2020

Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study

1 reference

12 December 2020

Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon

1 reference

12 December 2020

Diagnosis and treatment of diverticular disease: results of a consensus development conference. The Scientific Committee of the European Association for Endoscopic Surgery

1 reference

12 December 2020

Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease

1 reference

12 December 2020

Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon

1 reference

12 December 2020

Antioxidant activity of 5-aminosalicylic acid against peroxidation of phosphatidylcholine liposomes in the presence of alpha-tocopherol: a synergistic interaction?

1 reference

12 December 2020

Inflammatory bowel disease

1 reference

12 December 2020

Oxidants and free radicals in inflammatory bowel disease

1 reference

12 December 2020